Back to search results

CORRECT Trial: Improving Communication for Radiation Therapy

This study, called the CORRECT Trial, is testing a new way for doctors to share radiation therapy plans. It uses a system called the Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow. The goal is to improve how radiation oncologists (doctors who plan radiation treatment) and radiologists (doctors who interpret medical images) communicate and work together to identify cancer targets for radiation. This improved communication aims to prevent issues like giving too much or too little radiation, or misinterpreting imaging after treatment. This study is open to practices that treat at least 3 patients per month with lung cancer or head and neck cancer, and have at least one radiation oncologist and one radiologist willing to participate. The main goal is to see if radiology feedback can be returned through the CORRECT system within two business days.

Study design
This interventional study plans to enroll 194 participants. It involves training and using the CORRECT workflow, as well as surveys and interviews.
What's involved
Participants will receive training on the CORRECT workflow and practice with test cases. They will then use the CORRECT workflow with patient cases for 12 months.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint measures feasibility within 2 business days from receiving initial radiation therapy targets.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07282444

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

Not Yet Recruiting
NAAges 18+InterventionalHealth services
Wake Forest University Health Sciences
~194 participants
Updated 2026-07-24 on ClinicalTrials.gov
What's tested:Training and EducationCommunication InterventionSurvey AdministrationInterviewElectronic Health Record Review

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The return of radiology feedback via Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) (feasibility)
Measured over Within 2 business days from receipt of initial radiation therapy (RT) targets

Conditions

Lung Carcinoma
Head and Neck Carcinoma

Explore related trials

Head and Neck CarcinomaLung Carcinoma

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Kathryn Weaver, PhD · STUDY_CHAIR · Wake Forest University Health Sciences

Who to contact

Karen Craver
[email protected]
336-716-0891
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PRACTICE: Must provide radiation therapy for ≥ 3 patients per month with lung cancer or head \& neck cancer
PRACTICE: At least one radiation oncologist and one radiologist (in house, contracted, etc.) at the practice willing to participate, but may have multiple participants at the practice
PRACTICE: Radiation oncologist/radiologist team must use Picture Archiving and Communication System (PACS) software at this practice
RADIATION ONCOLOGIST (NON-PATIENT): Must have been in independent practice (i.e., performing duties without preceptor oversight) for a minimum of six months
RADIATION ONCOLOGIST (NON-PATIENT): Must treat lung and/or head \& neck cancer patients with curative intent radiation therapy
RADIATION ONCOLOGIST (NON-PATIENT): Willing and able to participate in 15 minutes of mandatory virtual CORRECT training
RADIATION ONCOLOGIST (NON-PATIENT): Willing to participate in a 30-minute interview, if selected at the end of the study
RADIOLOGIST (NON-PATIENT): Must have been in independent practice (i.e., performing duties without preceptor oversight) for a minimum of six months
RADIOLOGIST (NON-PATIENT): Agree to review pre-treatment radiation therapy targets during the course of the study duration (approximately 12 months). Willing and able to participate in 15 minutes of mandatory virtual CORRECT training
RADIOLOGIST (NON-PATIENT): Willing to participate in a 30-minute interview, if selected at the end of the study
PATIENT: Must have any stage of clinically diagnosed lung or head \& neck (HN) cancer
PATIENT: Planned treatment with curative intent definitive RT (with or without other treatments). Curative intent RT must be documented in the electronic medical record (EMR) by the treating radiation oncologist
PATIENT: Must be expected to be treated by a radiation oncologist participating in this study
PATIENT: Must be 18 years or older

Exclusion

PRACTICE: Participation by the Community Site or Minority/Underserved Community Site in another National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Cancer Care Delivery Research (CCDR) U34-supported protocol funded in NCI fiscal year 2025 or later. (Note: WF- 2301CD CONNECT is exempt from this policy, as it was funded prior to NCI fiscal year 2025.)
RADIATION ONCOLOGIST (NON-PATIENT): Planning to leave their position at this practice within the next 12 months
RADIATION ONCOLOGIST (NON-PATIENT): Providing service on a temporary basis (i.e., locum tenens providers)
RADIOLOGIST (NON-PATIENT): Planning to leave their position at this practice within the next 12 months
RADIOLOGIST (NON-PATIENT): Providing service on a temporary basis (i.e., locum tenens providers)
PATIENT: Unable to understand English or Spanish
PATIENT: Early glottic larynx cancer planned for definitive RT alone

What this trial measures

  • The return of radiology feedback via Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) (feasibility)Within 2 business days from receipt of initial radiation therapy (RT) targets

    If \> 50% of patients have target feedback returned to the radiation oncologist within 2 business days, this workflow will be considered feasible in community practice.